Biosensis/Leucine-Rich Repeat Kinase 2 inhibitor LRRK2-IN-1 (5mg)/PE-1608-5/5mg
Description | Leucine-Rich Repeat Kinase 2 (LRRK2) is a member of the leucine-rich repeat kinase family. Mutations in the LRRK2 gene have been linked with late-onset autosomal dominant Parkinsons disease (PD). A recent screening identified the analog LRRK2-IN-1 as a potent and selective inhibitor of LRRK2. This research by Deng et al (2011, Nat Chem Biol) showed that LRRK2-IN-1 suppressed LRRK2 kinase activity in vivo leading to dephosphorylation of Ser910/Ser935, loss of 14-3-3 binding and accumulation of LRRK2 within aggregrate fibrillar structures. LRRK2-IN-1, is the first selective and potent inhibitor of LRRK2. LRRK2-IN-1 inhibits both wild-type and G2019S mutant LRRK2 kinase activity with IC50 values of 13nM and 6nM respectively (Deng et al 2011, Nat Chem Biol). |
Related products | Leucine-Rich Repeat Kinase 2 inhibitor LRRK2-IN-1 (10mg) |
Batch No. | See product label |
Unit size | 5mg |
Other Names | Protein: Leucine-rich repeat serine/threonine-protein kinase 2; Dardarin; LRRK2; PARK8 |
Accession | Q5S007 LRRK2_HUMAN; |
Molecular Weight | 570.69g |
Compound Name | 2-((2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1- carbonyl)phenyl)amino)-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one |
Purity | >97% by HPLC |
Biol. activity | LRRK2-IN-1 inhibits both wild-type and G2019S mutant LRRK2 kinase activity with IC50 values of 13nM and 6nM respectively (Deng et al 2011, Nat Chem Biol). |
Applications | Biosensis recommends optimal dilutions/concentrations should be determined by the end user. |
Appearance | Dry powder |
Storage | Store dry, unopened vial protected from light for up to 3 months at RT or at -70ºC for up to 1 year. Reconstitute product in 100% ACS grade DMSO and store at -80ºC, in aliquots, protected from light, for up to 1 month. Prevent multiple freeze-thaw cycles. CAS Number 1234480-84-2. |
Expiry Date | See storage conditions |
Specific References | 1. Deng X. et al (2011) Characterization of a selective inhibitor of the Parkinsons disease kinase LRRK2 Nat Chem Biol. 2011 Apr;7(4):203-5. |